Screener › Small Caps Biotech
Small Caps Biotech
Empresas biotecnológicas de pequeña capitalización — alto potencial vinculado al desarrollo de pipelines clínicos y al riesgo binario regulatorio.
| Ticker | Empresa | Precio | Cap. Mercado | Potencial | Pos. 52S | Smart Money |
|---|---|---|---|---|---|---|
| ALHC | Alignment Healthcare | $24.05 -2.08% | $4.97B | 3.6% | 92.1% | — |
| VKTX | Viking Therapeutics | $42.13 +8.83% | $4.89B | 119.8% | 94.9% | — |
| INDV | Indivior Pharmaceuticals, Inc. | $40.83 +2.1% | $4.83B | 24.5% | 92.9% | — |
| EWTX | Edgewise Therapeutics | $43.13 +7.56% | $4.64B | 13.6% | 97.5% | — |
| LIVN | LivaNova PLC | $83.58 -0.54% | $4.59B | -2.5% | 96.2% | — |
| WAY | Waystar Holding Corp. | $23.81 -0.42% | $4.57B | 40.8% | 27.1% | — |
| FOLD | Amicus Therapeutics | $14.49 +0% | $4.55B | 0.1% | 99.9% | — |
| ACAD | Acadia Pharmaceuticals | $26.20 +1.67% | $4.49B | 23.3% | 75.2% | — |
| VCYT | Veracyte, Inc. | $56.16 -3.16% | $4.48B | -9.9% | 87.6% | — |
| NVST | Envista Holdings | $27.15 -1.31% | $4.42B | 9.4% | 71.9% | — |
| MMSI | Merit Medical Systems | $72.14 +0.97% | $4.3B | 24.1% | 33.5% | — |
| DNLI | Denali Therapeutics | $26.31 +2.21% | $4.18B | 29% | 96.6% | — |
| LFST | LifeStance Health Group, Inc. | $10.90 -0.82% | $4.16B | -3.2% | 90.9% | — |
| DOCS | Doximity, Inc. | $22.72 -0.61% | $4.15B | 7.3% | 9.4% | — |
| IRTC | iRhythm Technologies | $125.09 -0.75% | $4.11B | 43% | 21.8% | — |
| CON | Concentra Group Holdings Parent | $31.66 -0.57% | $4.05B | -0.5% | 95% | — |
| BEAM | Beam Therapeutics | $37.92 +7.36% | $3.9B | 34.7% | 98.5% | — |
| ICUI | ICU Medical, Inc. | $155.37 -2.55% | $3.88B | 11% | 87.7% | — |
| CPRX | Catalyst Pharmaceuticals, Inc. | $31.49 -0.03% | $3.85B | 0.6% | 92.1% | — |
| RCUS | Arcus Biosciences, Inc. | $30.29 +1.03% | $3.81B | 18% | 93.9% | — |
| FIE.DE | Fielmann | $43.70 -0.11% | $3.67B | 34.7% | 20.3% | — |
| OGN | Organon & Co. | $13.51 -0.37% | $3.55B | -16.7% | 98.9% | — |
| ARQT | Arcutis Biotherapeutics | $27.67 +6.14% | $3.46B | 25.1% | 77.7% | — |
| PRVA | Privia Health Group, Inc. | $27.23 +0.15% | $3.43B | 15.4% | 94.7% | — |
| HAE | Haemonetics Corporation | $74.90 -0.16% | $3.4B | 13.8% | 69% | — |
| OPCH | Option Care Health, Inc. | $21.57 +0.98% | $3.39B | 32.5% | 18.9% | — |
| NHC | National HealthCare Corporation | $216.05 -0.63% | $3.37B | — | 96.2% | — |
| SFZN.SW | Siegfried Holding | $72.20 -2.3% | $3.16B | 37.4% | 19.6% | — |
| CLDX | Celldex Therapeutics | $39.93 +5.22% | $3.13B | 44.1% | 98.2% | — |
| ITGR | Integer Holdings Corporation | $91.90 -1.61% | $3.12B | 6.2% | 49% | — |
| ACHC | Acadia Healthcare Company, Inc. | $31.92 +2.67% | $2.94B | -9.6% | 95.8% | — |
| SUPN | Supernus Pharmaceuticals, Inc. | $47.94 +1.48% | $2.78B | 31.1% | 58.5% | — |
| VIRP.PA | Virbac | $326.50 +0.46% | $2.74B | 26.5% | 32.6% | — |
| AGIO | Agios Pharmaceuticals | $44.01 +17.71% | $2.62B | -7.4% | 91.6% | — |
| NKTR | Nektar Therapeutics | $74.90 +2.39% | $2.53B | 104.6% | 61.2% | — |
| TMDX | TransMedics Group | $71.11 -0.16% | $2.46B | 65% | 11.5% | — |
| XRAY | DENTSPLY SIRONA Inc. | $12.19 -1.06% | $2.44B | 9.9% | 36.2% | — |
| LMAT | LeMaitre Vascular | $105.70 +1.91% | $2.42B | 12.4% | 68.4% | — |
| PGNY | Progyny, Inc. | $30.78 -0.48% | $2.41B | -2.2% | 96.2% | — |
| VCEL | Vericel Corporation | $46.95 +0.84% | $2.4B | 18.1% | 95.5% | — |
| PBH | Prestige Consumer Healthcare In | $50.42 +3.19% | $2.39B | 32.5% | 21.1% | — |
| ASTH | Astrana Health Inc. | $47.04 +0.28% | $2.33B | 0.2% | 86.4% | — |
| DMP.DE | Dermapharm Holding | $47.00 +0.97% | $2.33B | 7.2% | 75.7% | — |
| OCUL | Ocular Therapeutix | $10.33 +6.94% | $2.26B | 162.3% | 40.2% | — |
| HRMY | Harmony Biosciences Holdings, I | $38.26 +3.38% | $2.21B | 17.4% | 83% | — |
| MD | Pediatrix Medical Group, Inc. | $26.85 -1.97% | $2.2B | -13.7% | 93.2% | — |
| ZLAB | Zymeworks | $19.35 +1.42% | $2.19B | 72.1% | 13.4% | — |
| TECN.SW | Tecan Group | $172.30 -2.05% | $2.18B | -0.2% | 87.4% | — |
| ADMA | ADMA Biologics | $9.21 +0.55% | $2.13B | 91.1% | 15.1% | — |
| SRPT | Sarepta Therapeutics | $19.79 +3.18% | $2.09B | 11.2% | 62.9% | — |
| NVCR | NovoCure | $17.72 +2.31% | $2.05B | 46.7% | 86.8% | — |
| SEM | Select Medical Holdings Corpora | $16.51 -0.12% | $2.05B | -0.1% | 91% | — |
| NEOG | Neogen Corporation | $9.39 -1.26% | $2.04B | 27.8% | 70.3% | — |
| UFPT | UFP Technologies | $264.11 -2.93% | $2.04B | 22.9% | 85.4% | — |
| RXRX | Recursion Pharmaceuticals | $3.84 -3.03% | $2.04B | 73% | 24.3% | — |
| OMCL | Omnicell | $44.36 -1.95% | $2.02B | 38.2% | 62.2% | — |
| ANAB | AnaptysBio | $67.33 +8.05% | $1.99B | 29.4% | 91.7% | — |
| ADUS | Addus HomeCare Corporation | $105.97 +0.23% | $1.98B | 25.2% | 49.4% | — |
| ANIP | ANI Pharmaceuticals, Inc. | $85.99 +1.11% | $1.95B | 31.1% | 63.4% | — |
| IOVA | Iovance Biotherapeutics | $4.35 +3.82% | $1.94B | 102.3% | 67.5% | — |
| NEO | NeoGenomics, Inc. | $14.50 -4.35% | $1.89B | 4.2% | 90.1% | — |
| DVAX | Dynavax Technologies | $15.50 +0% | $1.82B | 3.2% | 50% | — |
| CMPS | COMPASS Pathways | $12.99 +1.17% | $1.75B | 71.9% | 80% | — |
| VIR | Vir Biotechnology, Inc. | $10.25 +2.3% | $1.73B | 110.3% | 81.2% | — |
| HCSG | Healthcare Services Group, Inc. | $24.39 -0.93% | $1.67B | 7.4% | 89.6% | — |
| FTRE | Fortrea Holdings Inc. | $17.48 -2.07% | $1.65B | -6.2% | 91.7% | — |
| INVA | Innoviva | $22.25 +1.97% | $1.64B | 59.6% | 66.4% | — |
| NVAX | Novavax | $9.46 +1.18% | $1.56B | 49.2% | 56.5% | — |
| PRGO | Perrigo Company plc | $11.19 +0.9% | $1.55B | 47.5% | 10.2% | — |
| DRW3.DE | Draegerwerk | $82.20 -3.18% | $1.54B | 23.5% | 53.4% | — |
| ENOV | Enovis Corporation | $25.52 -1.47% | $1.47B | 65.8% | 36.1% | — |
| PSNL | Personalis | $13.98 -2.51% | $1.46B | -22.3% | 92.3% | — |
| INSP | Inspire Medical Systems, Inc. | $50.08 +1.27% | $1.44B | 3.4% | 10.3% | — |
| ATEC | Alphatec Holdings | $9.38 +0.54% | $1.44B | 78.3% | 15.5% | — |
| FAE.MC | Faes Farma | $4.59 +0.66% | $1.43B | 17.5% | 36.6% | — |
| AHCO | AdaptHealth Corp. | $10.15 -1.17% | $1.38B | 37.9% | 33.4% | — |
| BLFS | BioLife Solutions, Inc. | $27.93 +0.5% | $1.36B | 15% | 82.9% | — |
| IART | Integra LifeSciences Holdings C | $17.46 -3.96% | $1.36B | -0.2% | 85.7% | — |
| PAHC | Phibro Animal Health Corporatio | $33.12 -2.96% | $1.34B | 37.7% | 21.9% | — |
| ARDX | Ardelyx | $5.38 +0.75% | $1.33B | 203% | 30.2% | — |
| STAA | STAAR Surgical Company | $26.55 -2.89% | $1.32B | 11.7% | 54% | — |
| CRVS | Corvus Pharmaceuticals | $15.63 +3.03% | $1.31B | 113.3% | 51% | — |
| MNKD | MannKind Corporation | $4.22 -1.17% | $1.3B | 80% | 46.5% | — |
| AMN | AMN Healthcare Services Inc | $33.25 -7.05% | $1.29B | -10.2% | 85.9% | — |
| SDGR | Schrodinger | $16.49 -3% | $1.23B | 26.6% | 43.3% | — |
| AORT | Artivion, Inc. | $24.46 -0.81% | $1.19B | 71.7% | 18.2% | — |
| COLL | Collegium Pharmaceutical, Inc. | $36.44 -2.75% | $1.18B | 49.1% | 33.6% | — |
| AZTA | Azenta, Inc. | $25.37 -1.17% | $1.17B | 3.3% | 36.6% | — |
| AVNS | Avanos Medical, Inc. | $24.92 +0% | $1.17B | — | 96.5% | — |
| XNCR | Xencor | $15.67 +5.24% | $1.16B | 81.9% | 74.3% | — |
| QDEL | QuidelOrtho Corporation | $17.00 -5.56% | $1.16B | 11% | 27.6% | — |
| OPK | OPKO Health | $1.49 -0.67% | $1.13B | 193.6% | 81% | — |
| CERT | Certara | $7.17 +0.56% | $1.12B | 4.3% | 28.8% | — |
| USPH | US Physical Therapy | $71.80 -2.15% | $1.09B | 30.5% | 38.5% | — |
| TNDM | Tandem Diabetes Care | $15.43 +0.06% | $1.06B | 87.1% | 27.7% | — |
| CNMD | Conmed Corporation | $34.24 -2.48% | $1.03B | 15.7% | 11.1% | — |
| PCRX | Pacira BioSciences, Inc. | $25.82 +0.9% | $1.02B | 14.9% | 79.4% | — |
| EUZ.DE | Eckert and Ziegler | $15.35 -3.15% | $960.5M | 44% | 21% | — |
| CBAV.MC | Clinica Baviera | $57.80 -1.03% | $926.3M | — | 81.6% | — |
| EVT.DE | Evotec | $5.04 -2.14% | $895.1M | 36.3% | 27.2% | — |
| AMPH | Amphastar Pharmaceuticals, Inc. | $20.08 +2.4% | $885.4M | 9.6% | 23.5% | — |
| INMD | InMode | $14.54 -0.41% | $835.8M | -1.4% | 45.3% | — |
| HSTM | HealthStream | $28.45 -2.13% | $831.2M | 12.5% | 85.2% | — |
| CTKB | Cytek Biosciences, Inc. | $4.56 -1.3% | $588.9M | 24.7% | 47.6% | — |
| EDIT | Editas Medicine | $3.75 +2.74% | $575.5M | 54.1% | 72.6% | — |
| LBIRD.PA | Lumibird | $26.00 -3.35% | $573.7M | 13.5% | 86.1% | — |
| WEAV | Weave Communications | $6.81 +1.64% | $541.8M | 28.5% | 54.9% | — |
| PACB | Pacific Biosciences | $1.56 -6.02% | $484.5M | 57.6% | 28.7% | — |
| CCCC | C4 Therapeutics | $4.35 +5.07% | $481M | 206.5% | 77.5% | — |
| EOLS | Evolent Health | $6.94 -0.72% | $457M | 111.3% | 48.6% | — |
| PRLD | Prelude Therapeutics | $4.97 -0.4% | $395.8M | 61% | 85.4% | — |
| REG1V.HE | Revenio Group | $12.56 +0.48% | $365.4M | 54.3% | 3.2% | — |
| FATE | Fate Therapeutics | $3.02 +1% | $352M | 79.2% | 91.7% | — |
| FYB.DE | Formycon | $18.70 -3.21% | $330.5M | 112.1% | 18.7% | — |
| TMCI | Treace Medical Concepts | $4.41 -3.29% | $286.1M | -9.3% | 49% | — |
| RNA | Avidity Biosciences | $13.24 +1.77% | $226.5M | 88.8% | 34.3% | — |
| SBS.DE | Stratec | $18.12 -1.84% | $220.3M | 40.2% | 10.8% | — |
| EMBC | Embecta Corp | $3.37 +2.74% | $199.9M | 18.7% | 4.7% | — |
| CRBU | Caribou Biosciences | $1.92 +4.92% | $190.4M | 525% | 25.1% | — |
| HCAT | Health Catalyst | $2.27 -0.87% | $167.7M | -16.3% | 41.5% | — |
| AMWL | Amwell | $8.99 -3.23% | $150.2M | -16.6% | 84.5% | — |
| VXRT | Vaxart | $0.55 -12.58% | $133.2M | 445.2% | 50.1% | — |
| SEER | Seer Bio | $2.22 +1.37% | $122.1M | 80.2% | 77.9% | — |
| HYPR | Hyperfine | $1.22 -3.94% | $121.1M | 77.6% | 31.5% | — |
| NNOX | Nano-X Imaging | $1.24 -6.06% | $86.3M | 367.7% | 10.2% | — |
| TELA | Tela Bio | $0.89 +13.67% | $40M | 151.7% | 23.1% | — |
| CTSO | Cytosorbents Corporation | $0.41 -5.4% | $25.6M | 606.7% | 6.5% | — |
| MARI.VI | Marinomed Biotech | $9.45 +0% | $18.9M | 429.1% | 6.9% | — |
Análisis y Contexto
Este screener sectorial muestra actualmente 128 acciones del segmento seleccionado — actualizado diariamente. El P/E medio es de 42.3x. El crecimiento medio de ingresos es del 19.1%. Los sectores atraviesan fases cíclicas fuertemente correlacionadas con factores macroeconómicos — tipos de interés, crecimiento del PIB, precios de materias primas y entorno regulatorio impulsan la dinámica sectorial. Los analistas ven un potencial medio del 55.1% en estos valores. Compara las métricas con la media sectorial para identificar sobre- e infravaloraciones relativas. La concentración sectorial aumenta el riesgo de cartera — mantén una diversificación adecuada entre industrias y modelos de negocio.
¿Listo para invertir?
Compara los mejores brokers para acciones de EE.UU. y Europa — comisiones, plataformas y tipos de cuenta cara a cara.
Comparar brokers →